The 2013 version of the European Association of Urology guidelines summarizes the evidence-based recommendations on early detection and diagnosis, staging, treatment, and follow-up of clinically organ-confined prostate cancer. The application of these guidelines in the counseling process for i...
Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Horwich,Parker,D Reijke,... - 《Annals of Oncology Official Journal of the European Society for Medical Oncology》 被引量: 109发表: 2013年 Prostate cancer: ESMO Clinical Practice Guidelines for diagnosis, ...
Management of Prostate Cancer: EAU Guidelines on Screening, Diagnosis and Local Primary Treatment The 2016 EAU-ESTRO-SIOG Prostate cancer guideline is based on systematic revues and follows a strict methodology. The main change regarding pathology is the 2014 ISUP grading system in five grades, on...
EAU Guidelines on Prostate Cancer. Part 1: Screening, Diagnosis, and Local Treatment with Curative Intent—Update 2013 The 2013 version of the European Association of Urology guidelines summarizes the evidence-based recommendations on early detection and diagnosis, staging,... A Heidenreich,PJ Bastian...
Nearly one-third of patients with prostate cancer (PCa) experience biochemical recurrence (BCR) after primary definitive treatment. BCR increases the risk of distant metastasis and mortality in patients with prognostically unfavorable features. These pat
Building a patient-focused relationship based on individual and family needs strengthens trust and mutual engagement throughout the cancer journey. Patient-centered communication is particularly important when developing a care plan: allaying fears, managing pain, and adverse treatment effects, as well ...
Cancer Samantha Greenberg, MS, MPH, CGC; Jonathan Tward, MD, PhD; Brock O’Neil, MD JAMA Oncology Key Points Question What is the germline mutational landscape in unselected patients with prostate cancer, and do guidelines for genetic testing adequately identify patients at risk for aggressive ...
Race is associated with discontinuation of active surveillance of low-risk prostate cancer. Prostate Cancer Prostatic Dis. 2013;16(1):85-90. PubMedGoogle ScholarCrossref 8. Sundi D, Faisal FA, Trock BJ, et al. Reclassification rates are higher among African American men than...
USA This review article will cover the evolution of grading of prostate cancer from the original Gleason system in the 1960–1970s to a more patient-centric grading system proposed in 2013 from a group at Johns Hopkins Hospital, validated in 2014 by a large multi-institutional study, and subse...
While prostate cancer is often indolent and treatment can be curative, prostate cancer represents the leading global cause of cancer-associated disability due to the negative effects of over- and under-treatment, and is a leading cause of cancer death in men2,3. Determining the optimal course ...